Diolife Meditech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.50 M
- Company Age 8 Year, 3 Months
- Last Filing with ROC 31 Mar 2018
- Open Charges ₹ 2.00 M
- Revenue Growth %
- Profit Growth -125.64%
- Ebitda -64.69%
- Net Worth -2531.61%
- Total Assets 832.09%
About Diolife Meditech
Diolife Meditech Private Limited (DMPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 October 2016 (Eight years and three months 28 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹2.00 M.
Subramanian Ishwaran and Savitri Iswaran serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74999DL2016PTC307222
-
Company No.
307222
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 Oct 2016
-
Date of AGM
29 Sep 2018
-
Date of Balance Sheet
31 Mar 2018
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Diolife Meditech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subramanian Ishwaran
|
Director | 17-Oct-2016 | Current |
|
Savitri Iswaran
|
Director | 17-Oct-2016 | Current |
Financial Performance of Diolife Meditech.
Diolife Meditech Private Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 125.64% decrease in profit. The company's net worth observed a substantial decline by a decrease of 2531.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Diolife Meditech?
In 2018, Diolife Meditech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Dio Cath Equip (India) Private LimitedSubramanian Ishwaran and Savitri Iswaran are mutual person
Charges (Loans)
₹2.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Jul 2017 | Others | ₹2.00 M | Open |
How Many Employees Work at Diolife Meditech?
Unlock and access historical data on people associated with Diolife Meditech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Diolife Meditech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Diolife Meditech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
